Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Genetic testing and PARP inhibitors in metastatic prostate cancer
Dr Neal Shore and Dr Joaquin Mateo
Genetic testing and PARP inhibitors in metastatic prostate cancer ( Dr Neal Shore and Dr Joaquin Mateo )
7 Jun 2019
Metastatic castration resistant prostate cancer: Updates from ASCO 2019
Dr Neal Shore, Dr Joaquin Mateo and Prof Karim Fizazi
Metastatic castration resistant prostate cancer: Updates from ASCO 2019 ( Dr Neal Shore, Dr Joaquin Mateo and Prof Karim Fizazi )
7 Jun 2019
Preliminary results of earlier steroid use with axicabtagene ciloleucel in patie...
Prof Max Topp - University of Würzburg, Würzburg, Germany
Preliminary results of earlier steroid use with axicabtagene ciloleucel in patients with R/R large B cell lymphoma ( Prof Max Topp - University of Würzburg, Würzburg, Germany )
6 Jun 2019
Evaluation of AMG 420, an anti-BCMA bispecific T-cell engager (BiTE) immunothera...
Prof Max Topp - University of Würzburg, Würzburg, Germany
Evaluation of AMG 420, an anti-BCMA bispecific T-cell engager (BiTE) immunotherapy in patients with R/R multiple myeloma ( Prof Max Topp - University of Würzburg, Würzburg, Germany )
6 Jun 2019
POLO Trial: Olaparib as a maintenance treatment following first-line chemotherap...
Dr Teresa Macarulla - Vall d’Hebron Barcelona University Hospital, Barcelona, Sp...
POLO Trial: Olaparib as a maintenance treatment following first-line chemotherapy in patients with metastatic pancreatic cancer ( Dr Teresa Macarulla - Vall d’Hebron Barcelona University Hospital, Barcelona, Spain )
6 Jun 2019
Breast cancer highlights from ASCO 2019
Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy
Breast cancer highlights from ASCO 2019 ( Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy )
6 Jun 2019
Weekly 20/56 mg/m² carfilzomib, lenalidomide and dexamethasone until progression...
Prof Xavier Leleu - Centre Hospitalier Universitaire de Lille, Lille, France
Weekly 20/56 mg/m² carfilzomib, lenalidomide and dexamethasone until progression in early relapsed refractory multiple myeloma ( Prof Xavier Leleu - Centre Hospitalier Universitaire de Lille, Lille, France )
6 Jun 2019
Maintenance with weekly carfilzomib in elderly newly diagnosed multiple myeloma
Prof Xavier Leleu - Centre Hospitalier Universitaire de Lille, Lille, France
Maintenance with weekly carfilzomib in elderly newly diagnosed multiple myeloma ( Prof Xavier Leleu - Centre Hospitalier Universitaire de Lille, Lille, France )
6 Jun 2019
Proton therapy or photon therapy as part of concurrent chemoradiotherapy for loc...
Prof Brian Baumann - Washington University in St. Louis, St. Louis, USA
Proton therapy or photon therapy as part of concurrent chemoradiotherapy for locally advanced cancer ( Prof Brian Baumann - Washington University in St. Louis, St. Louis, USA )
6 Jun 2019
Carfilzomib and irinotecan in relapsed small cell lung cancer
Dr Susanne Arnold - UK Markey Cancer Center, Lexington, USA
Carfilzomib and irinotecan in relapsed small cell lung cancer ( Dr Susanne Arnold - UK Markey Cancer Center, Lexington, USA )
6 Jun 2019
FORTE trial results: KRd with or without transplantation in newly diagnosed myel...
Dr Francesca Gay - University Hospital City of Health and Science of Turin, Turi...
FORTE trial results: KRd with or without transplantation in newly diagnosed myeloma according to risk status ( Dr Francesca Gay - University Hospital City of Health and Science of Turin, Turin, Italy )
6 Jun 2019
Olaparib and durvalumab in metastatic BRCA wild type triple-negative breast canc...
Dr Zahi Mitri - OHSU Hospital, Portland, USA
Olaparib and durvalumab in metastatic BRCA wild type triple-negative breast cancer ( Dr Zahi Mitri - OHSU Hospital, Portland, USA )
6 Jun 2019